Company: MDCXW
Filing Date: 2025-12-30
Form Type: S-3
Source: 0001062993-25-017488
Chunk: 43

Company: Medicus Pharma Ltd.
Filing Date: 2025-12-30
Form: S-3
Chunk 43
---
 by writing or telephoning the Company at the following address:

<div align='center'>Medicus Pharma Ltd.
Attention: Corporate Secretary
300 Conshohocken State Rd., Suite 200

W. Conshohocken, PA 19428

madesso@medicuspharma.com</div>

You should rely only on the information contained or incorporated by reference in this prospectus supplement. We have not authorized any person, including any salesman or broker, to provide information other than that provided in this prospectus supplement. We have not authorized anyone to provide you with different information. We do not take responsibility for, and can provide no assurance as to the reliability of, any information that others may give you. We are not making an offer of the securities in any jurisdiction where the offer is not permitted. You should not assume that the information in this prospectus supplement or any documents incorporated by reference is accurate as of any date other than the date of the applicable document.

Any statement contained in a document incorporated or deemed to be incorporated by reference into this prospectus supplement will be deemed to be modified or superseded for purposes of this prospectus supplement to the extent that a statement contained in this prospectus supplement or any other subsequently filed document that is deemed to be incorporated by reference into this prospectus supplement modifies or supersedes the statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement.

<div align='center'>S-22

Up to $15,349,674

PROSPECTUS</div>

| Maxim Group LLC | Yorkville Securities |

<div align='center'>, 2025

S-23

PART II
INFORMATION NOT REQUIRED IN PROSPECTUS</div>

Item 14. Other Expenses of Issuance and Distribution.

The following statement sets forth the expenses and costs expected to be incurred by the Company in connection with the distribution of its securities being registered in this registration statement.

| SEC registration fee               | $ | 13,810 |
| FINRA filing fee                   | $ | 15,500 |
| Transfer agent's fees and expenses | $ |      * |
| Legal fees and expenses            | $ |      * |
| Accounting fees and expenses       | $ |      * |
| Trustee fees and expenses          | $ |      * |
| Miscellaneous fees and expenses    | $ |      * |
| Total                              | $ |      * |

_____________________

|